KR101900520B1 - 복합 조성물 - Google Patents
복합 조성물 Download PDFInfo
- Publication number
- KR101900520B1 KR101900520B1 KR1020137014178A KR20137014178A KR101900520B1 KR 101900520 B1 KR101900520 B1 KR 101900520B1 KR 1020137014178 A KR1020137014178 A KR 1020137014178A KR 20137014178 A KR20137014178 A KR 20137014178A KR 101900520 B1 KR101900520 B1 KR 101900520B1
- Authority
- KR
- South Korea
- Prior art keywords
- paracetamol
- ibuprofen
- composition
- combined
- pain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Dermatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Rheumatology (AREA)
- Anesthesiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NZ58901110 | 2010-11-04 | ||
| NZ589011 | 2010-11-04 | ||
| PCT/NZ2011/000226 WO2012060719A1 (en) | 2010-11-04 | 2011-10-26 | A combination composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR20140025314A KR20140025314A (ko) | 2014-03-04 |
| KR101900520B1 true KR101900520B1 (ko) | 2018-09-19 |
Family
ID=46024668
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020137014178A Active KR101900520B1 (ko) | 2010-11-04 | 2011-10-26 | 복합 조성물 |
Country Status (28)
| Country | Link |
|---|---|
| US (6) | US20130225685A1 (https=) |
| EP (1) | EP2635269B1 (https=) |
| JP (2) | JP2013541583A (https=) |
| KR (1) | KR101900520B1 (https=) |
| CN (2) | CN103298464A (https=) |
| AU (1) | AU2011324137B2 (https=) |
| BR (1) | BR112013010829B8 (https=) |
| CA (1) | CA2814057C (https=) |
| CL (1) | CL2013001250A1 (https=) |
| CO (1) | CO6771406A2 (https=) |
| CY (1) | CY1123398T1 (https=) |
| DK (1) | DK2635269T3 (https=) |
| ES (1) | ES2742373T3 (https=) |
| HR (1) | HRP20191489T1 (https=) |
| HU (1) | HUE045442T2 (https=) |
| LT (1) | LT2635269T (https=) |
| MX (2) | MX2013005113A (https=) |
| MY (1) | MY160572A (https=) |
| NZ (1) | NZ609727A (https=) |
| PH (2) | PH12013500689A1 (https=) |
| PL (1) | PL2635269T3 (https=) |
| PT (1) | PT2635269T (https=) |
| RS (1) | RS59258B1 (https=) |
| RU (2) | RU2707089C2 (https=) |
| SG (1) | SG189319A1 (https=) |
| SI (1) | SI2635269T1 (https=) |
| SM (1) | SMT201900481T1 (https=) |
| WO (1) | WO2012060719A1 (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20130225685A1 (en) | 2010-11-04 | 2013-08-29 | Aft Pharmaceuticals Limited | Combination composition |
| US9072710B2 (en) | 2012-03-16 | 2015-07-07 | Cumberland Pharmaceuticals Inc. | Injectable ibuprofen formulation |
| WO2016008546A1 (en) | 2014-07-18 | 2016-01-21 | Everbright Pharmaceuticals S.A.R.L. | Aqueous formulation comprising paracetamol and ibuprofen |
| KR20170066549A (ko) * | 2014-10-06 | 2017-06-14 | 큠버랜드 파마슈티컬즈 인코포레이티드 | 통증 치료를 위한 이부프로펜과 아세트아미노펜의 공동 정맥 투여 |
| WO2018192664A1 (en) | 2017-04-20 | 2018-10-25 | Hyloris Developments Sa | METHOD FOR PREPARING A COMPOSITION WITH A LOW DISSOLVED OXYGEN CONTENT, COMPRISING ACETAMINOPHEN, AND OPTIONALLY ONE OR MORE NSAIDs, AND A COMPOSITION OBTAINED THEREOF |
| CN114681324B (zh) * | 2017-07-10 | 2024-05-03 | 盖尔凯普科技有限公司 | 双释放剂型胶囊及其制备方法、装置和系统 |
| US11197830B2 (en) | 2019-02-27 | 2021-12-14 | Aft Pharmaceuticals Limited | Pharmaceutical composition containing acetaminophen and ibuprofen |
| US11568752B2 (en) * | 2020-01-28 | 2023-01-31 | David Clark Company Incorporated | Gateway retrieval alert device for aircraft pushback operations |
| WO2023281089A2 (en) | 2021-07-08 | 2023-01-12 | Krka, D.D., Novo Mesto | Pharmaceutical composition comprising naproxen and paracetamol |
| IL324832A (en) | 2023-06-02 | 2026-01-01 | Ioulia Tseti | Pharmaceutical composition comprising ibuprofen |
| GR1010809B (el) * | 2023-09-13 | 2024-10-25 | Ιουλια Τσετη | Υδατικο διαλυμα ιβουπροφαινης παρακεταμολης για χρηση σε ενδοφλεβια χορηγηση |
| GR1010769B (el) * | 2023-07-27 | 2024-09-18 | Ιουλια Κλεωνος Τσετη | Υδατικο διαλυμα ιβουπροφαινης για χρηση σε ενδοφλεβια χορηγηση |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010044681A1 (en) * | 2008-10-14 | 2010-04-22 | Aft Pharmaceuticals Limited | A medicinal product and treatment |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997020551A1 (en) * | 1995-12-05 | 1997-06-12 | Adcock Ingram Limited | Pharmaceutical composition comprising a skeletal muscle relaxant, a non-steroidal antiinflammatory agent and an analgesic |
| DE60114249T2 (de) * | 2001-11-02 | 2006-05-18 | Cumberland Pharmaceuticals Inc., Nashville | Pharmazeutische zusammensetzung mit 2-(4-isobutylphenyl) propionsäure |
| CN1758904A (zh) * | 2003-03-21 | 2006-04-12 | 麦克内尔-Ppc股份有限公司 | 非甾体抗炎药物的给药方案 |
| ATE543491T1 (de) * | 2004-07-07 | 2012-02-15 | Aft Pharmaceuticals Ltd | Kombinationspräparat enthaltend ibuprofen und paracetamol |
| KR20060072839A (ko) * | 2004-12-23 | 2006-06-28 | 김경태 | 아세트아미노펜과 이부프로펜을 이용하여 통증조절과 해열작용을 하는 주사제 |
| US7934627B2 (en) * | 2005-10-13 | 2011-05-03 | Alcoa Inc. | Apparatus and method for high pressure extrusion with molten aluminum |
| CA2666582C (en) * | 2006-10-20 | 2014-09-09 | Mcneil-Ppc, Inc. | Acetaminophen / ibuprofen combinations |
| WO2008079818A2 (en) * | 2006-12-21 | 2008-07-03 | Soluprin Pharmaceuticals, Inc. | Intravenous administration of water soluble analgesic formulations |
| US20090264530A1 (en) * | 2008-04-16 | 2009-10-22 | Nickell Robert P | Combined nsaid and acetaminophen formulation and method |
| KR20140014350A (ko) * | 2009-03-12 | 2014-02-06 | 큠버랜드 파마슈티컬즈 인코포레이티드 | 정맥 내 투여용 이부프로펜의 투여 |
| SG186388A1 (en) * | 2010-07-07 | 2013-01-30 | Aft Pharmaceuticals Ltd | A combination composition comprising ibuprofen and paracetamol |
| US20130225685A1 (en) | 2010-11-04 | 2013-08-29 | Aft Pharmaceuticals Limited | Combination composition |
| KR20170066549A (ko) * | 2014-10-06 | 2017-06-14 | 큠버랜드 파마슈티컬즈 인코포레이티드 | 통증 치료를 위한 이부프로펜과 아세트아미노펜의 공동 정맥 투여 |
-
2011
- 2011-10-26 US US13/882,953 patent/US20130225685A1/en not_active Abandoned
- 2011-10-26 ES ES11838295T patent/ES2742373T3/es active Active
- 2011-10-26 CN CN2011800525659A patent/CN103298464A/zh active Pending
- 2011-10-26 RU RU2015103107A patent/RU2707089C2/ru active
- 2011-10-26 KR KR1020137014178A patent/KR101900520B1/ko active Active
- 2011-10-26 JP JP2013537631A patent/JP2013541583A/ja active Pending
- 2011-10-26 DK DK11838295.1T patent/DK2635269T3/da active
- 2011-10-26 PL PL11838295T patent/PL2635269T3/pl unknown
- 2011-10-26 BR BR112013010829A patent/BR112013010829B8/pt active IP Right Grant
- 2011-10-26 EP EP11838295.1A patent/EP2635269B1/en active Active
- 2011-10-26 LT LTEP11838295.1T patent/LT2635269T/lt unknown
- 2011-10-26 HR HRP20191489 patent/HRP20191489T1/hr unknown
- 2011-10-26 RS RSP20190963 patent/RS59258B1/sr unknown
- 2011-10-26 PT PT11838295T patent/PT2635269T/pt unknown
- 2011-10-26 CA CA2814057A patent/CA2814057C/en active Active
- 2011-10-26 NZ NZ609727A patent/NZ609727A/en unknown
- 2011-10-26 MX MX2013005113A patent/MX2013005113A/es not_active Application Discontinuation
- 2011-10-26 PH PH1/2013/500689A patent/PH12013500689A1/en unknown
- 2011-10-26 SI SI201131767T patent/SI2635269T1/sl unknown
- 2011-10-26 SG SG2013026265A patent/SG189319A1/en unknown
- 2011-10-26 SM SM20190481T patent/SMT201900481T1/it unknown
- 2011-10-26 RU RU2013123646/15A patent/RU2013123646A/ru not_active Application Discontinuation
- 2011-10-26 MX MX2015008709A patent/MX367209B/es unknown
- 2011-10-26 HU HUE11838295A patent/HUE045442T2/hu unknown
- 2011-10-26 AU AU2011324137A patent/AU2011324137B2/en active Active
- 2011-10-26 MY MYPI2013001237A patent/MY160572A/en unknown
- 2011-10-26 CN CN201710623266.5A patent/CN107519159A/zh active Pending
- 2011-10-26 WO PCT/NZ2011/000226 patent/WO2012060719A1/en not_active Ceased
-
2013
- 2013-05-06 CL CL2013001250A patent/CL2013001250A1/es unknown
- 2013-05-22 CO CO13125952A patent/CO6771406A2/es not_active Application Discontinuation
-
2015
- 2015-08-21 US US14/832,154 patent/US20160235695A1/en not_active Abandoned
-
2017
- 2017-03-22 JP JP2017055893A patent/JP6353577B2/ja active Active
-
2018
- 2018-10-01 US US16/149,109 patent/US11446266B2/en active Active
-
2019
- 2019-07-18 CY CY20191100766T patent/CY1123398T1/el unknown
-
2021
- 2021-04-08 PH PH12021550804A patent/PH12021550804A1/en unknown
-
2022
- 2022-09-13 US US17/943,708 patent/US11896567B2/en active Active
-
2024
- 2024-01-05 US US18/405,907 patent/US12220392B2/en active Active
- 2024-12-30 US US19/005,738 patent/US20250134839A1/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010044681A1 (en) * | 2008-10-14 | 2010-04-22 | Aft Pharmaceuticals Limited | A medicinal product and treatment |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101900520B1 (ko) | 복합 조성물 | |
| KR20180100309A (ko) | 데옥시콜산 및 이의 염을 사용한 축적된 지방의 치료 방법 | |
| AU2009304002B2 (en) | A medicinal product and treatment | |
| JP2019506397A5 (https=) | ||
| AU2011274652B2 (en) | A combination composition comprising ibuprofen and paracetamol | |
| CA2516458A1 (en) | Use of kahalalide compounds for the manufacture of a medicament for the treatment of psoriasis | |
| CN117243947A (zh) | 瑞香素及包含其的组合在制备糖尿病并发症药物中的应用 | |
| CN117243948A (zh) | 包含瑞香素的组合物在制备风湿性关节炎药物中的应用 | |
| GB2602123A (en) | Composition for procedural sedation and use thereof | |
| JPS5920221A (ja) | レイノ−症状の改善・治療剤 | |
| Safety | Higher-Dose Alzheimer’s Drug Gets FDA Approval | |
| RU2015147233A (ru) | Способы лечения, включающие эсликарбазепин или эсликарбазепина ацетат |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
St.27 status event code: A-0-1-A10-A15-nap-PA0105 |
|
| PG1501 | Laying open of application |
St.27 status event code: A-1-1-Q10-Q12-nap-PG1501 |
|
| A201 | Request for examination | ||
| PA0201 | Request for examination |
St.27 status event code: A-1-2-D10-D11-exm-PA0201 |
|
| D13-X000 | Search requested |
St.27 status event code: A-1-2-D10-D13-srh-X000 |
|
| D14-X000 | Search report completed |
St.27 status event code: A-1-2-D10-D14-srh-X000 |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
St.27 status event code: A-1-2-D10-D21-exm-PE0902 |
|
| T11-X000 | Administrative time limit extension requested |
St.27 status event code: U-3-3-T10-T11-oth-X000 |
|
| T11-X000 | Administrative time limit extension requested |
St.27 status event code: U-3-3-T10-T11-oth-X000 |
|
| T11-X000 | Administrative time limit extension requested |
St.27 status event code: U-3-3-T10-T11-oth-X000 |
|
| T11-X000 | Administrative time limit extension requested |
St.27 status event code: U-3-3-T10-T11-oth-X000 |
|
| T11-X000 | Administrative time limit extension requested |
St.27 status event code: U-3-3-T10-T11-oth-X000 |
|
| T13-X000 | Administrative time limit extension granted |
St.27 status event code: U-3-3-T10-T13-oth-X000 |
|
| AMND | Amendment | ||
| E13-X000 | Pre-grant limitation requested |
St.27 status event code: A-2-3-E10-E13-lim-X000 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| E601 | Decision to refuse application | ||
| PE0601 | Decision on rejection of patent |
St.27 status event code: N-2-6-B10-B15-exm-PE0601 |
|
| T11-X000 | Administrative time limit extension requested |
St.27 status event code: U-3-3-T10-T11-oth-X000 |
|
| T13-X000 | Administrative time limit extension granted |
St.27 status event code: U-3-3-T10-T13-oth-X000 |
|
| T11-X000 | Administrative time limit extension requested |
St.27 status event code: U-3-3-T10-T11-oth-X000 |
|
| T13-X000 | Administrative time limit extension granted |
St.27 status event code: U-3-3-T10-T13-oth-X000 |
|
| AMND | Amendment | ||
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| PX0901 | Re-examination |
St.27 status event code: A-2-3-E10-E12-rex-PX0901 |
|
| PX0701 | Decision of registration after re-examination |
St.27 status event code: A-3-4-F10-F13-rex-PX0701 |
|
| X701 | Decision to grant (after re-examination) | ||
| GRNT | Written decision to grant | ||
| PR0701 | Registration of establishment |
St.27 status event code: A-2-4-F10-F11-exm-PR0701 |
|
| PR1002 | Payment of registration fee |
St.27 status event code: A-2-2-U10-U12-oth-PR1002 Fee payment year number: 1 |
|
| PG1601 | Publication of registration |
St.27 status event code: A-4-4-Q10-Q13-nap-PG1601 |
|
| PR1001 | Payment of annual fee |
St.27 status event code: A-4-4-U10-U11-oth-PR1001 Fee payment year number: 4 |
|
| PR1001 | Payment of annual fee |
St.27 status event code: A-4-4-U10-U11-oth-PR1001 Fee payment year number: 5 |
|
| PR1001 | Payment of annual fee |
St.27 status event code: A-4-4-U10-U11-oth-PR1001 Fee payment year number: 6 |
|
| J204 | Request for invalidation trial [patent] | ||
| PJ0204 | Invalidation trial for patent |
St.27 status event code: A-5-5-V10-V11-apl-PJ0204 |
|
| J204 | Request for invalidation trial [patent] | ||
| PJ0204 | Invalidation trial for patent |
St.27 status event code: A-5-5-V10-V11-apl-PJ0204 |
|
| P22-X000 | Classification modified |
St.27 status event code: A-4-4-P10-P22-nap-X000 |
|
| PR1001 | Payment of annual fee |
St.27 status event code: A-4-4-U10-U11-oth-PR1001 Fee payment year number: 7 |
|
| S14-X000 | Exclusive voluntary license recorded |
St.27 status event code: A-4-4-S10-S14-lic-X000 |
|
| J301 | Trial decision |
Free format text: TRIAL NUMBER: 2023100003210; TRIAL DECISION FOR INVALIDATION REQUESTED 20230927 Effective date: 20250624 Free format text: TRIAL NUMBER: 2023100003209; TRIAL DECISION FOR INVALIDATION REQUESTED 20230927 Effective date: 20250624 Free format text: TRIAL NUMBER: 2023100003208; TRIAL DECISION FOR INVALIDATION REQUESTED 20230927 Effective date: 20250624 |
|
| PJ1301 | Trial decision |
St.27 status event code: A-5-5-V10-V15-crt-PJ1301 Decision date: 20250624 Appeal event data comment text: Appeal Kind Category : Invalidation, Appeal Ground Text : 1900520 Appeal request date: 20230927 Appellate body name: Patent Examination Board Decision authority category: Office appeal board Decision identifier: 2023100003208 Decision date: 20250624 Appeal event data comment text: Appeal Kind Category : Invalidation, Appeal Ground Text : 1900520 Appeal request date: 20230927 Appellate body name: Patent Examination Board Decision authority category: Office appeal board Decision identifier: 2023100003210 Decision date: 20250624 Appeal event data comment text: Appeal Kind Category : Invalidation, Appeal Ground Text : 1900520 Appeal request date: 20230927 Appellate body name: Patent Examination Board Decision authority category: Office appeal board Decision identifier: 2023100003209 |
|
| J301 | Trial decision |
Free format text: TRIAL NUMBER: 2023100003296; TRIAL DECISION FOR INVALIDATION REQUESTED 20231011 Effective date: 20250626 Free format text: TRIAL NUMBER: 2023100003295; TRIAL DECISION FOR INVALIDATION REQUESTED 20231011 Effective date: 20250626 Free format text: TRIAL NUMBER: 2023100003294; TRIAL DECISION FOR INVALIDATION REQUESTED 20231011 Effective date: 20250626 |
|
| PJ1301 | Trial decision |
St.27 status event code: A-5-5-V10-V15-crt-PJ1301 Decision date: 20250626 Appeal event data comment text: Appeal Kind Category : Invalidation, Appeal Ground Text : 1900520 Appeal request date: 20231011 Appellate body name: Patent Examination Board Decision authority category: Office appeal board Decision identifier: 2023100003295 Decision date: 20250626 Appeal event data comment text: Appeal Kind Category : Invalidation, Appeal Ground Text : 1900520 Appeal request date: 20231011 Appellate body name: Patent Examination Board Decision authority category: Office appeal board Decision identifier: 2023100003297 Decision date: 20250626 Appeal event data comment text: Appeal Kind Category : Invalidation, Appeal Ground Text : 1900520 Appeal request date: 20231011 Appellate body name: Patent Examination Board Decision authority category: Office appeal board Decision identifier: 2023100003296 Decision date: 20250626 Appeal event data comment text: Appeal Kind Category : Invalidation, Appeal Ground Text : 1900520 Appeal request date: 20231011 Appellate body name: Patent Examination Board Decision authority category: Office appeal board Decision identifier: 2023100003294 |
|
| PJ2001 | Appeal |
St.27 status event code: A-5-5-V10-V12-crt-PJ2001 |
|
| V12 | Court appeal requested |
Free format text: ST27 STATUS EVENT CODE: A-5-5-V10-V12-CRT-PJ2001 (AS PROVIDED BY THE NATIONAL OFFICE) |
|
| PJ1301 | Trial decision |
St.27 status event code: A-5-5-V10-V15-crt-PJ1301 Decision date: 20251022 Appeal event data comment text: Appeal Kind Category : Invalidation, Appeal Ground Text : 1900520 Appeal request date: 20231011 Appellate body name: Patent Examination Board Decision authority category: Office appeal board Decision identifier: 2023100003280 Decision date: 20251022 Appeal event data comment text: Appeal Kind Category : Invalidation, Appeal Ground Text : 1900520 Appeal request date: 20231011 Appellate body name: Patent Examination Board Decision authority category: Office appeal board Decision identifier: 2023100003292 Decision date: 20251022 Appeal event data comment text: Appeal Kind Category : Invalidation, Appeal Ground Text : 1900520 Appeal request date: 20231011 Appellate body name: Patent Examination Board Decision authority category: Office appeal board Decision identifier: 2023100003291 Decision date: 20251022 Appeal event data comment text: Appeal Kind Category : Invalidation, Appeal Ground Text : 1900520 Appeal request date: 20231011 Appellate body name: Patent Examination Board Decision authority category: Office appeal board Decision identifier: 2023100003290 Decision date: 20251022 Appeal event data comment text: Appeal Kind Category : Invalidation, Appeal Ground Text : 1900520 Appeal request date: 20231011 Appellate body name: Patent Examination Board Decision authority category: Office appeal board Decision identifier: 2023100003289 Decision date: 20251022 Appeal event data comment text: Appeal Kind Category : Invalidation, Appeal Ground Text : 1900520 Appeal request date: 20231011 Appellate body name: Patent Examination Board Decision authority category: Office appeal board Decision identifier: 2023100003288 Decision date: 20251022 Appeal event data comment text: Appeal Kind Category : Invalidation, Appeal Ground Text : 1900520 Appeal request date: 20231011 Appellate body name: Patent Examination Board Decision authority category: Office appeal board Decision identifier: 2023100003287 Decision date: 20251022 Appeal event data comment text: Appeal Kind Category : Invalidation, Appeal Ground Text : 1900520 Appeal request date: 20231011 Appellate body name: Patent Examination Board Decision authority category: Office appeal board Decision identifier: 2023100003286 Decision date: 20251022 Appeal event data comment text: Appeal Kind Category : Invalidation, Appeal Ground Text : 1900520 Appeal request date: 20231011 Appellate body name: Patent Examination Board Decision authority category: Office appeal board Decision identifier: 2023100003285 Decision date: 20251022 Appeal event data comment text: Appeal Kind Category : Invalidation, Appeal Ground Text : 1900520 Appeal request date: 20231011 Appellate body name: Patent Examination Board Decision authority category: Office appeal board Decision identifier: 2023100003284 Decision date: 20251022 Appeal event data comment text: Appeal Kind Category : Invalidation, Appeal Ground Text : 1900520 Appeal request date: 20231011 Appellate body name: Patent Examination Board Decision authority category: Office appeal board Decision identifier: 2023100003283 Decision date: 20251022 Appeal event data comment text: Appeal Kind Category : Invalidation, Appeal Ground Text : 1900520 Appeal request date: 20231011 Appellate body name: Patent Examination Board Decision authority category: Office appeal board Decision identifier: 2023100003275 Decision date: 20251022 Appeal event data comment text: Appeal Kind Category : Invalidation, Appeal Ground Text : 1900520 Appeal request date: 20231011 Appellate body name: Patent Examination Board Decision authority category: Office appeal board Decision identifier: 2023100003293 Decision date: 20251022 Appeal event data comment text: Appeal Kind Category : Invalidation, Appeal Ground Text : 1900520 Appeal request date: 20231011 Appellate body name: Patent Examination Board Decision authority category: Office appeal board Decision identifier: 2023100003281 Decision date: 20251022 Appeal event data comment text: Appeal Kind Category : Invalidation, Appeal Ground Text : 1900520 Appeal request date: 20231011 Appellate body name: Patent Examination Board Decision authority category: Office appeal board Decision identifier: 2023100003282 |
|
| V15 | Decision substituted |
Free format text: ST27 STATUS EVENT CODE: A-5-5-V10-V15-CRT-PJ1301 (AS PROVIDED BY THE NATIONAL OFFICE); DECISION IDENTIFIER: 2023100003280; DECISION AUTHORITY: OFFICE APPEAL BOARD, APPEAL KIND CATEGORY : INVALIDATION Free format text: ST27 STATUS EVENT CODE: A-5-5-V10-V15-CRT-PJ1301 (AS PROVIDED BY THE NATIONAL OFFICE); DECISION IDENTIFIER: 2023100003292; DECISION AUTHORITY: OFFICE APPEAL BOARD, APPEAL KIND CATEGORY : INVALIDATION Free format text: ST27 STATUS EVENT CODE: A-5-5-V10-V15-CRT-PJ1301 (AS PROVIDED BY THE NATIONAL OFFICE); DECISION IDENTIFIER: 2023100003291; DECISION AUTHORITY: OFFICE APPEAL BOARD, APPEAL KIND CATEGORY : INVALIDATION Free format text: ST27 STATUS EVENT CODE: A-5-5-V10-V15-CRT-PJ1301 (AS PROVIDED BY THE NATIONAL OFFICE); DECISION IDENTIFIER: 2023100003290; DECISION AUTHORITY: OFFICE APPEAL BOARD, APPEAL KIND CATEGORY : INVALIDATION Free format text: ST27 STATUS EVENT CODE: A-5-5-V10-V15-CRT-PJ1301 (AS PROVIDED BY THE NATIONAL OFFICE); DECISION IDENTIFIER: 2023100003289; DECISION AUTHORITY: OFFICE APPEAL BOARD, APPEAL KIND CATEGORY : INVALIDATION Free format text: ST27 STATUS EVENT CODE: A-5-5-V10-V15-CRT-PJ1301 (AS PROVIDED BY THE NATIONAL OFFICE); DECISION IDENTIFIER: 2023100003288; DECISION AUTHORITY: OFFICE APPEAL BOARD, APPEAL KIND CATEGORY : INVALIDATION Free format text: ST27 STATUS EVENT CODE: A-5-5-V10-V15-CRT-PJ1301 (AS PROVIDED BY THE NATIONAL OFFICE); DECISION IDENTIFIER: 2023100003287; DECISION AUTHORITY: OFFICE APPEAL BOARD, APPEAL KIND CATEGORY : INVALIDATION Free format text: ST27 STATUS EVENT CODE: A-5-5-V10-V15-CRT-PJ1301 (AS PROVIDED BY THE NATIONAL OFFICE); DECISION IDENTIFIER: 2023100003286; DECISION AUTHORITY: OFFICE APPEAL BOARD, APPEAL KIND CATEGORY : INVALIDATION Free format text: ST27 STATUS EVENT CODE: A-5-5-V10-V15-CRT-PJ1301 (AS PROVIDED BY THE NATIONAL OFFICE); DECISION IDENTIFIER: 2023100003285; DECISION AUTHORITY: OFFICE APPEAL BOARD, APPEAL KIND CATEGORY : INVALIDATION Free format text: ST27 STATUS EVENT CODE: A-5-5-V10-V15-CRT-PJ1301 (AS PROVIDED BY THE NATIONAL OFFICE); DECISION IDENTIFIER: 2023100003284; DECISION AUTHORITY: OFFICE APPEAL BOARD, APPEAL KIND CATEGORY : INVALIDATION Free format text: ST27 STATUS EVENT CODE: A-5-5-V10-V15-CRT-PJ1301 (AS PROVIDED BY THE NATIONAL OFFICE); DECISION IDENTIFIER: 2023100003283; DECISION AUTHORITY: OFFICE APPEAL BOARD, APPEAL KIND CATEGORY : INVALIDATION Free format text: ST27 STATUS EVENT CODE: A-5-5-V10-V15-CRT-PJ1301 (AS PROVIDED BY THE NATIONAL OFFICE); DECISION IDENTIFIER: 2023100003275; DECISION AUTHORITY: OFFICE APPEAL BOARD, APPEAL KIND CATEGORY : INVALIDATION Free format text: ST27 STATUS EVENT CODE: A-5-5-V10-V15-CRT-PJ1301 (AS PROVIDED BY THE NATIONAL OFFICE); DECISION IDENTIFIER: 2023100003293; DECISION AUTHORITY: OFFICE APPEAL BOARD, APPEAL KIND CATEGORY : INVALIDATION Free format text: ST27 STATUS EVENT CODE: A-5-5-V10-V15-CRT-PJ1301 (AS PROVIDED BY THE NATIONAL OFFICE); DECISION IDENTIFIER: 2023100003281; DECISION AUTHORITY: OFFICE APPEAL BOARD, APPEAL KIND CATEGORY : INVALIDATION Free format text: ST27 STATUS EVENT CODE: A-5-5-V10-V15-CRT-PJ1301 (AS PROVIDED BY THE NATIONAL OFFICE); DECISION IDENTIFIER: 2023100003282; DECISION AUTHORITY: OFFICE APPEAL BOARD, APPEAL KIND CATEGORY : INVALIDATION |
|
| PJ0202 | Trial for correction |
St.27 status event code: A-5-5-V10-V11-apl-PJ0202 |
|
| V11 | Administrative appeal requested |
Free format text: ST27 STATUS EVENT CODE: A-5-5-V10-V11-APL-PJ0202 (AS PROVIDED BY THE NATIONAL OFFICE) |